Yüklüyor......
Management of specialty drugs, specialty pharmacies and biosimilars in the United States
Background: Specialty medicines continue to increase as a percentage of spending with biologics representing a large portion of specialty spending. Health plans expect to adjust their formularies to maximize expected savings from biosimilars. Objectives: A better understanding of health plan managem...
Kaydedildi:
| Yayımlandı: | J Drug Assess |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764408/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658331 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|